Manufacturer record

Maneesh Pharmaceuticals Ltd: regulatory record

Last checked 20 September 2026. Source: CDSCO monthly NSQ alerts and state drug-testing laboratories

3 batches manufactured by Maneesh Pharmaceuticals Ltd (Himachal Pradesh) were declared Not of Standard Quality between April 2020 and April 2026. Records are batch-specific findings by government laboratories as published in CDSCO's monthly alerts; where a company has stated that a flagged batch was counterfeit, that statement is noted when reported.

Records by type

3 records linked to Maneesh Pharmaceuticals Ltd in the datasets we hold. A zero means nothing is on record in those datasets, not that nothing ever happened. What the labels mean.

0Banned or prohibited
0Recalled or suspended
3Failed a lab test
0Regulatory notice
Primary government sourceTier 1: government primary source

CDSCO drug alerts: Not of Standard Quality and spurious drugs

CDSCO · CDSCO monthly NSQ alerts, Apr 2020 to Apr 2026

View original document

Scope. A company appearing here is not a finding that its products are unsafe. Regulatory actions can apply to one batch, one formulation, one period or one state. Always check the linked government document for the current position, and tell us if something is out of date. How we label records.

3
NSQ batches since 2020
3
Products affected
Dissolution
Most common failure
Apr 2026
Latest alert

Flagged batches per year

2020 · 12023 · 12026 · 1

All flagged batches

Product Batch Reason declared NSQ Tested by Alert
Doxylamine Succinate & Pyridoxine Hydrochloride Tablets DXM2534Mfg 2025-07 · Exp 2028-06 The sample received does not conform to Manufacturers specification with respect to the test for ThicknessOther CDTL, MumbaiCDSCO lab Apr 2026
Doxylamine Succinate, Pyridoxine Hydrochloride and Folic Acid Tablets. (Doxinate Forte) DOFM2202Mfg 2022-02 · Exp 2025-01 DisintegrationDisintegration RDTL GuwahatiState lab Nov 2023
Rosuvastatin Tablets IP 10mg (ROZUDOC-10 TABLETS) RAE1901Mfg 2019-03 · Exp 2021-02 DissolutionDissolution RDTL ChandigarhCDSCO lab Apr 2020

Right of reply. Manufacturers may submit a response or a laboratory re-test result; it is published unedited alongside this record. Submit a response.